JP4426023B2 - 大腸癌抑制遺伝子関連蛋白質 - Google Patents

大腸癌抑制遺伝子関連蛋白質 Download PDF

Info

Publication number
JP4426023B2
JP4426023B2 JP23480999A JP23480999A JP4426023B2 JP 4426023 B2 JP4426023 B2 JP 4426023B2 JP 23480999 A JP23480999 A JP 23480999A JP 23480999 A JP23480999 A JP 23480999A JP 4426023 B2 JP4426023 B2 JP 4426023B2
Authority
JP
Japan
Prior art keywords
polypeptide
amino acid
acid sequence
apc
gene product
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
JP23480999A
Other languages
English (en)
Japanese (ja)
Other versions
JP2001057888A (ja
JP2001057888A5 (enExample
Inventor
徹 秋山
善博 川崎
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Daiichi Sankyo Co Ltd
Original Assignee
Daiichi Sankyo Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Daiichi Sankyo Co Ltd filed Critical Daiichi Sankyo Co Ltd
Priority to JP23480999A priority Critical patent/JP4426023B2/ja
Publication of JP2001057888A publication Critical patent/JP2001057888A/ja
Publication of JP2001057888A5 publication Critical patent/JP2001057888A5/ja
Application granted granted Critical
Publication of JP4426023B2 publication Critical patent/JP4426023B2/ja
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Images

Landscapes

  • Peptides Or Proteins (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
JP23480999A 1999-08-20 1999-08-20 大腸癌抑制遺伝子関連蛋白質 Expired - Lifetime JP4426023B2 (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP23480999A JP4426023B2 (ja) 1999-08-20 1999-08-20 大腸癌抑制遺伝子関連蛋白質

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP23480999A JP4426023B2 (ja) 1999-08-20 1999-08-20 大腸癌抑制遺伝子関連蛋白質

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2009208771A Division JP4579328B2 (ja) 2009-09-10 2009-09-10 大腸癌抑制遺伝子関連蛋白質

Publications (3)

Publication Number Publication Date
JP2001057888A JP2001057888A (ja) 2001-03-06
JP2001057888A5 JP2001057888A5 (enExample) 2006-08-31
JP4426023B2 true JP4426023B2 (ja) 2010-03-03

Family

ID=16976740

Family Applications (1)

Application Number Title Priority Date Filing Date
JP23480999A Expired - Lifetime JP4426023B2 (ja) 1999-08-20 1999-08-20 大腸癌抑制遺伝子関連蛋白質

Country Status (1)

Country Link
JP (1) JP4426023B2 (enExample)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7297779B2 (en) 2002-11-24 2007-11-20 Daiichi Pharmaceutical Co., Ltd. Colon cancer metastasis inhibitor
JP3792655B2 (ja) 2003-01-20 2006-07-05 日本電気株式会社 新規な癌遺伝子、該癌遺伝子由来の組換えタンパク質、およびそれらの用途
KR101512678B1 (ko) 2014-07-01 2015-04-17 대구대학교 산학협력단 Igα-2 chain C를 함유하는 대장암 진행예측용 바이오마커 조성물 및 이를 포함하는 대장암 진단용 바이오키트
CN109320592A (zh) * 2018-09-20 2019-02-12 山西医科大学 用于治疗结肠癌的多肽、多肽组合物及其应用
CN114014928B (zh) * 2021-10-27 2023-05-12 南京安吉生物科技有限公司 抗hmmw抗体、包含该抗体的组合物、编码该抗体的核酸分子及其用途

Also Published As

Publication number Publication date
JP2001057888A (ja) 2001-03-06

Similar Documents

Publication Publication Date Title
JP2004516227A (ja) 免疫関連疾患を治療するための組成物と方法
JP3497133B2 (ja) Ａ−３３関連抗原およびそれらの薬理学的使用
WO1999014241A2 (en) Compositions and methods for the treatment of immune related diseases
EP1205546B1 (en) Polypeptide and nucleic acids encoding the same
JP4426023B2 (ja) 大腸癌抑制遺伝子関連蛋白質
US7235633B2 (en) Cytokine receptors and nucleic acids encoding the same
JP2003530082A (ja) 免疫関連疾患を治療するための組成物及び方法
JP4579328B2 (ja) 大腸癌抑制遺伝子関連蛋白質
PL204844B1 (pl) Izolowany polinukleotyd, polinukleotyd antysensowny, izolowany polipeptyd, przeciwciało monoklonalne lub jego fragment wiążący antygen, wektor ekspresyjny, komórka gospodarza transformowana lub transfekowana wektorem ekspresyjnym, kompozycja farmaceutyczna, zastosowanie izolowanego polipeptydu
US20050266490A1 (en) Secreted and transmembrane polypeptides and nucleic acids encoding the same
EP1757692A1 (en) GENE ENCODING GUANINE NUCLEOTIDE EXCHANGE FACTOR BINDING TO RhoA
AU2002313838C1 (en) Novel PRO866 polypeptides and nucleic acids encoding same
US20020142432A1 (en) Human endosulfine gene
EP1209168B1 (en) PRO243 polypeptides and nucleic acids encoding the same
AU2002330288C1 (en) Novel PRO213-1 PRO1330 and PRO1449 polypeptides and nucleic acids encoding same
EP1757690A1 (en) Gene encoding guanine nucleotide exchange factor and its gene product
EP1241186A2 (en) Human growth arrest specific gene 6 (gas-6) and nucleic acids encoding the same
EP1217006B1 (en) Polypeptides and nucleic acids encoding the same
NZ525914A (en) Novel polypeptides and nucleic acids encoding the same
NZ528697A (en) Novel PRO362 polypeptides and nucleic acids encoding same with homology to A33 antigen and HCAR membrane bound protein
US20070178539A1 (en) Novel Cytokine Receptors and Nucleic Acids Encoding the Same
NZ528702A (en) Novel PRO792 polypeptides and nucleic acids encoding same with homology to CD23
JP2006212003A (ja) がん抑制遺伝子産物関連タンパク質
CA2245340A1 (en) Traf4-associating protein

Legal Events

Date Code Title Description
A521 Written amendment

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20060713

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20060713

A711 Notification of change in applicant

Free format text: JAPANESE INTERMEDIATE CODE: A712

Effective date: 20081022

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20090715

A521 Written amendment

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20090910

TRDD Decision of grant or rejection written
A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

Effective date: 20091118

A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

A61 First payment of annual fees (during grant procedure)

Free format text: JAPANESE INTERMEDIATE CODE: A61

Effective date: 20091210

R150 Certificate of patent or registration of utility model

Ref document number: 4426023

Country of ref document: JP

Free format text: JAPANESE INTERMEDIATE CODE: R150

Free format text: JAPANESE INTERMEDIATE CODE: R150

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20121218

Year of fee payment: 3

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20121218

Year of fee payment: 3

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20131218

Year of fee payment: 4

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

EXPY Cancellation because of completion of term